Late effects in survivors of teenage and young adult cancer: Does age matter?

Annals of Oncology

Volumn 22, Issue 12, 2011, Pages 2561-2568

  Woodward, E ^a,b   Jessop, M ^a,c   Glaser, A ^a   Stark, D ^a,b  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c Queensland Children's Cancer Centre   (Australia)

Author keywords

Adolescents; Cancer; Late effects; Morbidity; Teenager; Young adult

Indexed keywords

CISPLATIN;

AGE DISTRIBUTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM TUMOR; ENDOCRINE DISEASE; FERTILITY; GERM CELL TUMOR; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; LEUKEMIA; LUNG DISEASE; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; ONSET AGE; PRIORITY JOURNAL; REVIEW; SARCOMA; SECOND CANCER; SIDE EFFECT; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; THYROID CANCER;

EID: 82355191851     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr044     Document Type: Review

References (69)

1. Department of Health, Macmillan Cancer Support and NHS Improvement. The National Cancer Survivorship Initiative Vision. 2010. http://www.dh.gov.uk/ prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_111477.pdf (15 June 2010, date last accessed).
2. Oeffinger KC, Mertens AC, Sklar CA et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355(15): 1572-1582.
3. Skinner R, Wallace WH, Levitt GA. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol 2006; 7(6): 489-498.
4. Hudson MM, Bowers DC et al. High-risk populations identified in Childhood Cancer Survival Study investigations: implications for risk-based surveillance. J Clin Oncol 2009; 27(14): 2405-2414.
5. Birch JM, Alston RD, Kelsey AM et al. Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer 2002; 87(11): 1267-1274.
6. Bleyer A, Viny A, Barr R. Cancer in 15- to 29-year-olds by primary site. Oncologist 2006; 11(6): 590-601.
7. Rogers C, Jenney M, Cox H et al. on behalf of the National Institute for Health and Clinical Excellence. Improving outcomes in children and young people with cancer. 2005 http://www.nice.org.uk/nicemedia/live/10899/28876/28876.pdf (15 June 2010, date last accessed).
8. Neglia JP, Friedman DL, Yasui Y et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001; 93(8): 618-629.
9. van Leeuwen FE, Klokman WJ, Veer MB et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000; 18(3): 487-497.
10. Munker R, Grutzner S, Hiller E et al. Second malignancies after Hodgkin's disease: the Munich experience. Ann Hematol 1999; 78(12): 544-554.
11. Ng AK, Bernardo MV, Weller E et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002; 100(6): 1989-1996.
12. Foss Abrahamsen A, Andersen A, Nome O et al. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. Ann Oncol 2002; 13(11): 1786-1791.
13. Cellai E, Magrini SM, Masala G et al. The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital. Int J Radiat Oncol Biol Phys 2001; 49(5): 1327-1337.
14. Hodgson DC, Gilbert ES, Dores GM et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 2007; 25(12): 1489-1497.
15. Andersson A, Enblad G, Tavelin B et al. Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma. Br J Cancer 2008; 98(5): 1001-1005.
16. Schonfeld SJ, Gilbert ES, Dores GM et al. Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients. J Natl Cancer Inst 2006; 98(3): 215-218.
17. De Bruin ML, Sparidans J, van't Veer MB et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009; 27(26): 4239-4246.
18. Basu SK, Schwartz C, Fisher SG et al. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys 2008; 72(1): 34-40.
19. Wahner-Roedler DL, Nelson DF, Croghan IT et al. Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience. Mayo Clin Proc 2003; 78(6): 708-715.
20. De Bruin ML, Burgers JA, Baas P et al. Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood 2009; 113(16): 3679-3681.
21. Chemaitilly W MA, Mitby P, Whitton J et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006; 91(5): 1723-1728.
22. Byrne J, Fears TR, Mills JL et al. Fertility of long-term male survivors of acute lymphoblastic leukemia diagnosed during childhood. Pediatr Blood Cancer 2004; 42(4): 364-372.
23. Mulrooney DA, Yeazel MW, Kawashima T et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009; 339: b4606.
24. Swerdlow AJ, Higgins CD, Smith P et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007; 99(3): 206-214.
25. Reinders JG, Heijmen BJ, Olofsen-van Acht MJ et al. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 1999; 51(1): 35-42.
26. Aleman BM, van den Belt-Dusebout AW, De Bruin ML et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007; 109(5): 1878-1886.
27. Andersson A, Naslund U, Tavelin B et al. Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors-retrospective cohort analyses anda concept for prospective intervention. Int J Cancer 2009; 124(8): 1914-1917.
28. Mertens AC, Yasui Y, Liu Y et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer 2002; 95(11): 2431-2441.
29. De Bruin ML, Dorresteijn LD, van't Veer MB et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 2009; 101(13): 928-937.
30. Garmey EG, Liu Q, Sklar CA et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2008; 26(28): 4639-4645.
31. Razzouk BI, Rose SR, Hongeng S et al. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J Clin Oncol 2007; 25(10): 1183-1189.
32. Meacham LR, Gurney JG, Mertens AC et al. Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivor Study. Cancer 2005; 103(8): 1730-1739.
33. Kadan-Lottick NS, Dinu I, Wasilewski-Masker K et al. Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2008; 26(18): 3038-3045.
34. Kaste SC, Rai SN, Fleming K et al. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2006; 46(1): 77-87.
35. Sklar C, Whitton J, Mertens A et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000; 85(9): 3227-3232.
36. Thompson AL, Marsland AL, Marshal MP, Tersak JM. Romantic relationships of emerging adult survivors of childhood cancer. Psychooncology 2009; 18(7): 767-774.
37. Glover DA, Byrne J, Mills JL et al. Impact of CNS treatment on mood in adult survivors of childhood leukemia: a report from the Children's Cancer Group. J Clin Oncol 2003; 21(23): 4395-4401.
38. Lown EA, Goldsby R, Mertens AC et al. Alcohol consumption patterns and risk factors among childhood cancer survivors compared to siblings and general population peers. Addiction 2008; 103(7): 1139-1148.
39. Zebrack BJ, Chesler M. Health-related worries, self-image, and life outlooks of long-term survivors of childhood cancer. Health Soc Work 2001; 26(4): 245-256.
40. Mitby PA, Robison LL, Whitton JA et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 2003; 97(4): 1115-1126.
41. Pang JW, Friedman DL, Whitton JA et al. Employment status among adult survivors in the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2008; 50(1): 104-110.
42. Gurney JG, Ness KK, Stovall M et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab 2003; 88(10): 4731-4739.
43. Packer RJ, Gurney JG, Punyko JA et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 2003; 21(17): 3255-3261.
44. Fouladi M, Langston J, Mulhern R et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol 2000; 18(4): 824-831.
45. Koch SV, Kejs AM, Engholm G et al. Educational attainment among survivors of childhood cancer: a population-based cohort study in Denmark. Br J Cancer 2004; 91(5): 923-928.
46. Ji J, Hemminki K. Second primary malignancies among patients with soft tissue tumors in Sweden. Int J Cancer 2006; 119(4): 909-914.
47. Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF Jr.. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 2005; 103(11): 2391-2396.
48. Kaste SC. Skeletal toxicities of treatment in children with cancer. Pediatr Blood Cancer 2008; 50 (2 Suppl): 469-473discussion 86.
49. Felder-Puig R, Formann AK, Mildner A et al. Quality of life and psychosocial adjustment of young patients after treatment of bone cancer. Cancer 1998; 83(1): 69-75.
50. Nagarajan R, Neglia JP, Clohisy DR et al. Education, employment, insurance, and marital status among 694 survivors of pediatric lower extremity bone tumors: a report from the childhood cancer survivor study. Cancer 2003; 97(10): 2554-2564.
51. Travis LB, Fossa SD, Schonfeld SJ et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005; 97(18): 1354-1365.
52. Wanderas EH, Fossa SD, Tretli S. Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. Eur J Cancer 1997; 33(2): 244-252.
53. MacArthur AC, Spinelli JJ, Rogers PC et al. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. Pediatr Blood Cancer 2007; 48(4): 453-459.
54. Hammal DM, Bell CL, Craft AW, Parker L. Second primary tumors in children and young adults in the North of England (1968-99). Pediatr Blood Cancer 2005; 45(2): 155-161.
55. van den Belt-Dusebout AW, Nuver J, de Wit R et al. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2006; 24(3): 467-475.
56. Fossa SD, Gilbert E, Dores GM et al. Noncancer causes of death in survivors of testicular cancer. J Natl Cancer Inst 2007; 99(7): 533-544.
57. Fossa SD, Aass N, Winderen M et al. Long-term renal function after treatment for malignant germ-cell tumours. Ann Oncol 2002; 13(2): 222-228.
58. Brown AP, Chen J, Hitchcock YJ et al. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 2008; 93(2): 504-515.
59. Shusterman S, Meadows AT. Long term survivors of childhood leukemia. Curr Opin Hematol 2000; 7(4): 217-222.
60. von der Weid NX. Adult life after surviving lymphoma in childhood. Support Care Cancer 2008; 16(4): 339-345.
61. Henderson TO, Amsterdam A, Bhatia S et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 2010; 152(7): 444-455; W144-54.
62. Kenney LB, Yasui Y, Inskip PD et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004; 141(8): 590-597.
63. Perkins JL, Liu Y, Mitby PA et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2005; 23(16): 3733-3741.
64. Garwicz S, Anderson H, Olsen JH et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer 2000; 88(4): 672-678.
65. Armstrong GT. Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol 2010; 14(4): 298-303.
66. Ganz P. Pediatric cancer survivorship: the Childhood Cancer Survivor Study-editor's foreword. J Clin Oncol 2009; 27: 2307.
67. Gaya AM, Ashford RF. Cardiac complications of radiation therapy. Clin Oncol (R Coll Radiol) 2005; 17(3): 153-159.
68. Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE. Radiationassociated cardiovascular disease. Crit Rev Oncol Hematol 2003; 45(1): 55-75.
69. Travis LB, Rabkin CS, Brown LM et al. Cancer survivorship-genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 2006; 98(1): 15-25.